An artificial intelligence-based blink rate detection test could help predict, diagnose and stage dry eye disease.

SCREEN-ROP can effectively identify infants who require treatment for retinopathy of prematurity, a study shows.

Though 45% of patients said they could see the benefits of AI in health care, 44% said the idea of AI in health care settings ...

Patients in the US with newly diagnosed GCA face excessive delays to initiating subcutaneous TCZ, as well high out-of-pocket costs.

Live zoster vaccination is associated with a lower risk for overall cardiovascular events when compared with no vaccination.

The head of the US Food and Drug Administration (FDA) reiterated Tuesday that the agency is applying a more skeptical approach to this year’s round of COVID-19 vaccine boosters.

The Trump administration has canceled more than $800 million in research focused on LGBTQ health, cutting hundreds of studies on cancer, HIV and other diseases that affect sexual and gender minority ...

Nontobacco nicotine use in U.S. youth shifted from 2023 to 2024 toward greater use of nicotine pouches, according to a study published online April 30 in JAMA N ...

More than 75,000 cases comprising more than 1.8 million cartons of consumer level dry eye drops have been voluntarily recalled.

The US Food and Drug Administration (FDA) has chosen Dr. Vinay Prasad, a professor at the University of California-San Francisco, to lead its Center for Biologics Evaluation and Research.

Most Americans surveyed said they do not support the Trump administration’s recent cuts to staff and spending at federal health agencies.

Reproxalap ophthalmic solution 0.25% reached the primary endpoint in a second phase 3 dry eye chamber trial, according to Aldeyra Therapeutics.